Research findings, pricing news, and vendor analysis across the peptide market.
Showing 1 to 24 of 24
Tesamorelin prices vary sharply by vial size, discount, and testing proof. Compare current 2026 cost per mg, the strongest vendor checkpoints, and the human visceral-fat evidence before buying.
Read more →SS-31 prices in PeptidePub’s August 2026 catalog range from $2.80 to $19.30 per mg before discounts. Compare vial sizes, after-code value, COA proof, and benefit fit against MOTS-c before buying.
Read more →NAD+ IV drips commonly cost hundreds of dollars per session, but the NAD+ itself is only one part of the bill. Compare clinic prices by dose, current NAD+ price per mg, service fees, vendor proof, and the questions worth asking before paying.
Read more →Peptide prices vary wildly because buyers are comparing different vial sizes, stack formats, testing standards, and discount rules. This guide shows how to calculate the real price per mg, verify COAs, and use deals without letting the coupon pick the vendor.
Read more →There is still no FDA-approved generic Ozempic, Wegovy, Mounjaro, or Zepbound that US patients can buy in pharmacies. Tentative approvals and FDA review filings are real milestones, but they are not the same as available generic supply.
Read more →The compounded GLP-1 market has not fully shut down, but it has shifted. This tracker shows which telehealth providers now emphasize brand or direct-pay routes, which still advertise compounded semaglutide or tirzepatide, and what FDA says buyers should verify before paying.
Read more →The Medicare GLP-1 Bridge starts July 1, 2026 and can bring eligible obesity GLP-1 prescriptions to $50 per month, but only if the patient, indication, drug formulation, prior authorization, and pharmacy claim all line up. Use this checklist to prepare before launch and compare cash-pay backup options if the Bridge does not fit.
Read more →Zepbound can be covered by insurance in 2026, but coverage depends on your plan, formulary, diagnosis, prior authorization rules, and whether the plan treats obesity drugs differently from diabetes drugs. Check benefits first, then compare the Zepbound savings card, LillyDirect self-pay routes, Medicare Bridge timing, Medicaid rules, and cash-pay tirzepatide backup options.
Read more →If your employer drops GLP-1 weight-loss coverage, first separate diabetes coverage from obesity coverage, then confirm denial reasons, appeal if documentation is missing, and compare brand self-pay or vetted telehealth cash-pay options. The fastest backup path is usually a reputable cash-pay program, but the safest choice depends on your drug, diagnosis, budget, and need for FDA-approved medication.
Read more →Foundayo may cost as little as $25 with eligible commercial coverage, $50 through the Medicare GLP-1 Bridge, or about $149 to $299 through direct-pay channels. This guide explains who actually qualifies, what CVS Caremark changed, and when cash-pay GLP-1 backups still make sense.
Read more →GLP-1 insurance coverage is improving in pieces, but plan rules still decide what you actually pay. This tracker explains commercial formularies, Medicare Bridge access, prior authorization, and when cash-pay telehealth backup options still matter.
Read more →CVS Caremark says Zepbound will return to its commercial formularies as an additional preferred option on October 1, 2026, while Lilly's oral GLP-1 Foundayo gets a June 1 coverage path where plans approve it. This guide explains what the change does and does not mean, how to check your own benefits, and when cash-pay or telehealth alternatives still matter.
Read more →Canadian GLP-1 savings depend on the exact drug, indication, province, insurance plan, pharmacy price, and manufacturer program. This guide shows what to check before paying for Ozempic, Wegovy, Mounjaro, or Zepbound.
Read more →Starting July 1, 2026, eligible Medicare Part D beneficiaries can access select GLP-1 obesity drugs through the Medicare GLP-1 Bridge for $50 per month. This guide explains who may qualify, what is still not covered, and how it compares with cash-pay options.
Read more →Compounded tirzepatide commonly costs about $249 to $349 per month through online programs, but the real answer depends on dose, labs, support, and whether brand-name Zepbound cash-pay vials are now the better value. This guide compares the main cost buckets and shows who each option fits.
Read more →There is no single official public approved Mounjaro provider list for weight-loss shoppers. This guide explains how to verify legitimate Zepbound and tirzepatide access, compare online providers, and avoid risky sellers before paying.
Read more →The best online tirzepatide program depends on whether you prioritize lowest price, medication choice, coaching, or nurse support. This guide compares Eden Health, SkinnyRx, Medvi, and Direct Meds with buyer-focused pricing notes and decision criteria.
Read more →There are dozens of online weight loss programs. Most aren't worth your money. We reviewed the ones that are — ranked by pricing, medications, and the support you actually get.
Read more →Brand-name Wegovy costs $1,350/month. Compounded semaglutide starts at $149/month online. Here's where to get it, what to look for, and what to avoid.
Read more →Brand Zepbound costs $1,069/month. Compounded tirzepatide starts around $249/month. But is it legit? Here's what real users report and what to look for.
Read more →Without insurance, brand-name GLP-1s cost $12,000–$16,000 per year. Here are real, legal ways to get the same medications for $149–$349/month — no insurance needed.
Read more →Compounded GLP-1s cost a fraction of brand-name Wegovy or Zepbound. But are they the same drug? An honest breakdown of 503A vs 503B pharmacies, what's identical, what's different, and how to decide.
Read more →Wegovy costs $1,350/month. Zepbound costs $1,069/month. Here's how to pay 50–80% less — through insurance navigation, manufacturer savings programs, compounding pharmacies, and telehealth platforms starting at $149/mo.
Read more →The Trump administration announced deals with Eli Lilly and Novo Nordisk to significantly reduce the cost of weight loss medications through TrumpRx. Here's what we know and what it means for people taking semaglutide or tirzepatide.
Read more →STOP PIECING IT TOGETHER
We wrote the shortcut: five books, 45 compounds, every claim graded by the strength of the real evidence. No hype, no gatekeeping, and free updates for life whenever the market shifts. Most readers say it replaces months of forum digging.
